A validated composite comorbidity index predicts outcomes of CAR T-cell therapy in patients with diffuse large B-cell lymphomaGeoffrey Shouse, Alexey V. Danilov, Agrima Mian et al.|Blood Advances|2023Cited by 49
Prognostic value of early positron emission tomography in patients with large B-cell lymphoma treated with anti-CD19 chimeric antigen receptor T-cell therapyJennifer L. Crombie, Brian Hess, Caron A. Jacobson et al.|Haematologica|2023Cited by 6
Prognostic Value of Early PET in Patients with Aggressive Non-Hodgkin Lymphoma Treated with Anti-CD19 CAR T-Cell TherapyJennifer L. Crombie, Brian Hess, Robert Redd et al.|Blood|2021Cited by 3
Abstract 3980: Non-canonical CAR T cell states correlate with durable therapeutic responses in multiple myeloma patientsKai Wu, Lawrence Fong, Karen Law et al.|Cancer Research|2026Cited by 0